Table 2.

Treatment and outcome of Graves’ disease developing after alemtuzumab therapy

	Fluctuating Graves’ disease	“Conventional” Graves’ disease
Number	7	2
Therapy	–	–
ATD treatment, n	3	1
“Block and replace” ATD treatment in the minimum dose of each therapeutic agent, n	2	1
“Block and replace” ATD treatment in the minimum dose of each therapeutic agent, plus RAI, n	1	0
“Block and replace ATD” treatment in the minimum dose of each therapeutic agent, plus surgery (total thyroidectomy), n	1	0
Outcome	–	–
Resolution, n	1 (with euthyroidism after ocrelizumab)	0
Graves’ ophthalmopathy, n	4	0

ATD antithyroid drug; RAI radioactive iodine